e-learning
resources
Berlin 2008
Sunday, 05.10.2008
COPD - clinical and epidemiological aspects
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
High prevalence of vertebral deformities in COPD patients is not related only to systemic steroid use
A. Kjensli, M. S. Ryg, J. A. Falch, I. Ellingsen (Hakadal, Oslo, Norway)
Source:
Annual Congress 2008 - COPD - clinical and epidemiological aspects
Session:
COPD - clinical and epidemiological aspects
Session type:
Thematic Poster Session
Number:
1167
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Kjensli, M. S. Ryg, J. A. Falch, I. Ellingsen (Hakadal, Oslo, Norway). High prevalence of vertebral deformities in COPD patients is not related only to systemic steroid use. Eur Respir J 2008; 32: Suppl. 52, 1167
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
High prevalence of vertebral deformities in COPD patients: relationship to disease severity
Source: Eur Respir J 2009; 33: 1018-1024
Year: 2009
Osteoporosis and its relation with severity of COPD and steroids use
Source: International Congress 2019 – Comorbidities in COPD and asthma: body composition and diabetes
Year: 2019
Vertebral deformity and hyperkyphosis in people with chronic obstructive pulmonary disease
Source: International Congress 2016 – Latest insights into chronic care
Year: 2016
The effects of inhaled corticosteroids on risk of self-reported osteoporosis and fractures in adult subjects with asthma
Source: International Congress 2017 – Asthma epidemiology among children and adults: from biomarkers to ACOS
Year: 2017
Combined therapy of severe osteoporosis for patients with bronchial asthma
Source: Eur Respir J 2001; 18: Suppl. 33, 47s
Year: 2001
The absolute risk of osteoporotic fractures according to the program of FRAX patients with chronic obstructive pulmonary disease
Source: Annual Congress 2012 - COPD is not a pulmonary disease alone
Year: 2012
Severity of obstructive airway disease and risk of osteoporotic fracture
Source: Eur Respir J 2005; 25: 879-884
Year: 2005
Prevalence and associated factors of osteoporosis among patients with chronic obstructive pulmonary disease
Source: Annual Congress 2010 - Comorbidity in obstructive airway disease
Year: 2010
Long-term inhaled corticosteroid use in COPD and the risk of fracture in men and women
Source: International Congress 2016 – Novel avenues in the treatment of COPD I
Year: 2016
FRAX program as a method of assessing the risk of osteoporotic fractures in patients with chronic obstructive pulmonary disease
Source: Annual Congress 2012 - COPD is not a pulmonary disease alone
Year: 2012
The decrease of nutritional status and increasing of the risk of osteoporotic fractures in patients with chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2013 –COPD biomarkers
Year: 2013
Plasma osteoprotegerin is related to femoral osteoporosis in patients with COPD
Source: Annual Congress 2013 –COPD mechanisms
Year: 2013
Osteoporosis risk assessment in elderly male patients with COPD who use inhaled corticosteroids
Source: Annual Congress 2006 - COPD therapy
Year: 2006
High steroid burden in children with asthma and nasal symptoms
Source: Eur Respir J 2001; 18: Suppl. 33, 288s
Year: 2001
Osteoporosis and fracture risk associated with inhaled corticosteroid use among Swedish COPD patients: the ARCTIC study
Source: Eur Respir J, 57 (2) 2000515; 10.1183/13993003.00515-2020
Year: 2021
Osteoporosis risk associated with chronic corticoid inhalation therapy in patients with COPD
Source: Annual Congress 2009 - Prognosis and comorbidities in COPD
Year: 2009
Reduced risk of next exacerbation and mortality associated with antibiotic use in COPD
Source: Eur Respir J 2009; 33: 282-288
Year: 2009
Influence of polymorphisms in the Col1a1, CTR and VDR genes on the risk of low bone density and osteoporotic fractures in patients with severe asthma receiving oral glucocorticoids
Source: Eur Respir J 2006; 28: Suppl. 50, 323s
Year: 2006
Dose dependent increased mortality risk in COPD patients treated with oral glucocorticoids
Source: Eur Respir J 2001; 17: 337-342
Year: 2001
Measures of adherence in patients with severe asthma prescribed systemic steroids in the U-BIOPRED cohort
Source: International Congress 2018 – Clinical markers of asthma
Year: 2018
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept